Studies show that people with psoriasis, especially those with severe cases, have a much higher risk of heart disease than ...

The U.S. Food and Drug Administration has approved Zoryve (roflumilast) topical foam 0.3 percent for the treatment of plaque ...

Psoriasis is a chronic inflammatory skin condition that can impact quality of life. Many individuals with psoriasis also have ...

Users call it “without a doubt the best sunscreen I have ever used ,” and “a must-have in my middle-aged skincare routine,” ...

Psoriasis is often considered to be a skin condition, but it’s actually a systemic disease that can lead to symptoms such as ...

Central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than total body fat, particularly ...

Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than ...

Researchers further explored the relationship between suicidality and skin disease, with a focus on completed suicide among these patients.

Air pollution significantly contributes to and worsens various dermatologic conditions through oxidative stress, inflammation ...

The FDA approved a supplemental new drug application for roflumilast topical foam 0.3% for the treatment of plaque psoriasis ...

Topical roflumilast 0.3% cream has been approved by the FDA to treat plaque psoriasis in patients 12 years and older since ...